FDA Inspection
Ajanta Pharma USA IncAjanta Pharma USA Inc – FDA Inspection, Mar 17, 2016
Record Details
This FDA Inspection record concerns Ajanta Pharma USA Inc, with an inspection on March 17, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Ajanta Pharma USA Inc
- Inspection Date
- March 17, 2016
- Product Type
- Drugs
View Company Profile
ID · 923413a9-339f-459b-b453-59bc8a5fed91
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 965140
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 314.81(b)(2)Timely submission
- 21 CFR 314.80(c)(2)Late submission of quarterly safety reports
- 21 CFR 314.80(c)(2)Interval
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ajanta Pharma USA Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 22, 2025 | VAI | New Jersey District Office | Postmarketing Surveillance and Epidemiology: Human Drugs |
| April 4, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Ajanta Pharma USA Inc
- FDA Inspection 1276284 - 2025-07-22
- FDA Inspection 1049436 - 2018-04-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.